Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Johnston, I
Title
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
Citation
Blood; 2020 Apr 9; 135(15) pg1270-1280
PubMed ID
32077913
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P05
Human
Flow cytometry
First Author
Auerbach, D J
Title
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor.
Citation
Proceedings of the National Academy of Sciences of the United States of America; 2012 Jun 12; 109(24) pg9569-74
PubMed ID
22645343
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P05
Human
Immunoprecipitation
500-P05
Human
Binding Assay
First Author
Rauova, L
Title
Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
Citation
Blood; 2006 Mar 15; 107(6) pg2346-53
PubMed ID
16304054
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P05
Human
Western Blot
First Author
Rauova, L
Title
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia.
Citation
Blood; 2005 Jan 1; 105(1) pg131-8
PubMed ID
15304392
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P05
Human
Western Blot
First Author
Nassar, T
Title
Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells.
Citation
The Journal of Biological Chemistry; 2003 Feb 21; 278(8) pg6187-93
PubMed ID
12466273
Show Usages
Product Cited
Cross-Reactivity
Applications
500-P05
Human
Immunostaining
showing 5 of 5